Nucleoside Analogue Reverse Transcriptase Inhibitors Differentially Inhibit Human LINE-1 Retrotransposition
2008

How Antiretroviral Drugs Affect LINE-1 Retrotransposition

publication Evidence: moderate

Author Information

Author(s): Jones R. Brad, Garrison Keith E., Wong Jessica C., Duan Erick H., Nixon Douglas F., Ostrowski Mario A.

Primary Institution: Department of Immunology, University of Toronto

Hypothesis

Can nucleoside analogue reverse transcriptase inhibitors (nRTIs) inhibit LINE-1 retrotransposition?

Conclusion

NRTIs can suppress LINE-1 retrotransposition, which may have implications for their use in treating HIV and understanding LINE-1's role in physiological processes.

Supporting Evidence

  • NRTIs like stavudine and lamivudine were found to inhibit LINE-1 retrotransposition.
  • The study showed varying potencies of different nRTIs in suppressing LINE-1 activity.
  • Stavudine achieved the highest level of inhibition among the tested nRTIs.

Takeaway

Some medicines used to treat HIV can stop a part of our DNA called LINE-1 from copying itself, which might be important for how our bodies work.

Methodology

An in vitro LINE-1 retrotransposition reporter assay was used to evaluate the effects of various nRTIs on LINE-1 retrotransposition.

Limitations

The study only assessed one LINE-1 element and may not represent the behavior of all LINE-1 elements in the human genome.

Digital Object Identifier (DOI)

10.1371/journal.pone.0001547

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication